Browsing Tag
Scorpion Therapeutics
2 posts
Eli Lilly acquires promising PI3Kα inhibitor from Scorpion Therapeutics
Eli Lilly and Company (Lilly) has announced a significant acquisition of Scorpion Therapeutics’ mutant-selective PI3Kα inhibitor program, a…
January 15, 2025
Scorpion Therapeutics unveils promising Phase 1/2 clinical data for STX-478 in advanced solid tumors
Scorpion Therapeutics, Inc. has presented initial clinical data from its Phase 1/2 trial of STX-478, a mutant-selective PI3Kα…
September 15, 2024